Baxter Healthcare pharmaceuticals expands in WA

Construction works are complete on a new world-class pharmaceutical compounding centre in Perth which will manufacture lifesaving medicines and help to diversify Western Australia’s economy.

The facility will be one of the most technologically advanced compounding centres in Australia and has been supported by the state government’s Investment Attraction Fund.

The new Baxter Healthcare facility in Canning Vale will be one of the most technologically advanced compounding sites in the country, producing tailored medicines for patients across Western Australia – including lifesaving cancer treatments, according to a statement.

Baxter Healthcare already employs around 60 people in Western Australia, and the new facility will support the company to increase its local workforce with 20 new highly skilled pharmaceutical manufacturing jobs in the first three years.

The project will help to strengthen WA’s sovereign capabilities in medical manufacturing, with Baxter Healthcare to expand its production of lifesaving medicines by more than 50 per cent.

WA Premier Roger Cook said: “Baxter Healthcare’s new facility is the best in the nation, and means we can produce more medicines right here in WA – saving lives and advancing our sovereign capability.

“Through the Investment Attraction Fund, we’re supporting major projects that diversify our economy and create quality local jobs for the future.”

The centre is currently progressing towards its Therapeutic Goods Administration licensing and will begin production in the coming months.

The state provided a $4 million grant which helped to secure the facility for Western Australia.

It is one of seven Health and Medical Life Sciences sector projects supported in the IAF’s inaugural round, with nearly $24 million allocated between the projects.

Picture: Roger Cook